These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18245649)

  • 1. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease.
    Lämmle B; Kremer Hovinga JA; George JN
    Haematologica; 2008 Feb; 93(2):172-7. PubMed ID: 18245649
    [No Abstract]   [Full Text] [Related]  

  • 2. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
    Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
    Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.
    Zheng XL
    Annu Rev Med; 2015; 66():211-25. PubMed ID: 25587650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
    Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Jian C; Xiao J; Gong L; Skipwith CG; Jin SY; Kwaan HC; Zheng XL
    Blood; 2012 Apr; 119(16):3836-43. PubMed ID: 22289888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel frameshift mutations in ADAMTS13 in two families with hereditary thrombotic thrombocytopenic purpura.
    Alsultan A; Jarrar M; Al-Harbi T; A L Balwi M
    Pediatr Blood Cancer; 2013 Sep; 60(9):1559-60. PubMed ID: 23677910
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura.
    Grillberger R; Casina VC; Turecek PL; Zheng XL; Rottensteiner H; Scheiflinger F
    Haematologica; 2014 Apr; 99(4):e58-60. PubMed ID: 24532042
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura.
    Lämmle B; Kremer Hovinga J; Studt JD; Mansouri Taleghani B; Alberio L
    Hematol J; 2004; 5 Suppl 3():S6-11. PubMed ID: 15190269
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: III. Diagnosis and treatment; 4. Thrombotic thrombocytopenic purpura].
    Matsumoto M
    Nihon Naika Gakkai Zasshi; 2014 Jul; 103(7):1613-21. PubMed ID: 25154256
    [No Abstract]   [Full Text] [Related]  

  • 10. Unraveling the immunologic response in thrombotic thrombocytopenic purpura.
    Knöbl P
    J Thromb Haemost; 2006 Nov; 4(11):2352-4. PubMed ID: 16938122
    [No Abstract]   [Full Text] [Related]  

  • 11. Limited renal prophylaxis in regular plasmatherapy for heritable ADAMTS13 deficiency.
    Doi T; Ohga S; Ito N; Ishimura M; Suga N; Nomura A; Takada H; Matsumoto M; Fujimura Y; Hara T
    Pediatr Blood Cancer; 2013 Sep; 60(9):1557-8. PubMed ID: 23630191
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura.
    Peyvandi F; Palla R; Lotta LA
    Haematologica; 2010 Sep; 95(9):1444-7. PubMed ID: 20807984
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving on nature: redesigning ADAMTS13.
    Kremer Hovinga JA; Voorberg J
    Blood; 2012 Apr; 119(16):3654-5. PubMed ID: 22517874
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.
    Zheng XL; Wu HM; Shang D; Falls E; Skipwith CG; Cataland SR; Bennett CL; Kwaan HC
    Haematologica; 2010 Sep; 95(9):1555-62. PubMed ID: 20378566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity.
    Rossio R; Lotta LA; Pontiggia S; Borsa NG; Garagiola I; Ardissino G; Mikovic D; Cugno M; Peyvandi F
    Haematologica; 2015 Mar; 100(3):e87-9. PubMed ID: 25381125
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterisation of autoantibody repertoire is needed in thrombotic thrombocytopenia purpura.
    Scally B; Loan J
    Thromb Res; 2013 Sep; 132(3):e165. PubMed ID: 23768450
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
    Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M
    Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura.
    Luken BM; Kaijen PH; Turenhout EA; Kremer Hovinga JA; van Mourik JA; Fijnheer R; Voorberg J
    J Thromb Haemost; 2006 Nov; 4(11):2355-64. PubMed ID: 16898953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired TTP: ADAMTS13 meets the immune system.
    Verbij FC; Fijnheer R; Voorberg J; Sorvillo N
    Blood Rev; 2014 Nov; 28(6):227-34. PubMed ID: 25213289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Yamaguchi Y; Moriki T; Igari A; Nakagawa T; Wada H; Matsumoto M; Fujimura Y; Murata M
    Thromb Res; 2011 Aug; 128(2):169-73. PubMed ID: 21496883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.